Mitral regurgitation following PASCAL mitral valve repair system: A single arm meta-analysis

Major consequences of untreated severe mitral regurgitation (MR) includes heart failure, ventricular remodeling and pulmonary hypertension leading to significant morbidity and mortality. MitraClip is the most widely used device for treatment of severe MR. To overcome some of the shortcomings of Mitr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kansara, Tikal, Kumar, Ashish, Majmundar, Monil, Basman, Craig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961240/
https://www.ncbi.nlm.nih.gov/pubmed/33714399
http://dx.doi.org/10.1016/j.ihj.2020.12.003
Descripción
Sumario:Major consequences of untreated severe mitral regurgitation (MR) includes heart failure, ventricular remodeling and pulmonary hypertension leading to significant morbidity and mortality. MitraClip is the most widely used device for treatment of severe MR. To overcome some of the shortcomings of MitraClip, novel devices like PASCAL mitral valve repair system are developed. We performed a single arm meta-analysis for patients with severe mitral regurgitation (MR) undergoing PASCAL mitral valve repair system. The results showed that 93.8% patients had reduction in MR grade, with an average operative time of 88 min and an average increase of 86.33 m in 6-min walk test.

Ejemplares similares